LONDON and PHOENIX, April 28, 2022 (GLOBE NEWSWIRE) — AccuStem Sciences, Inc. (OTCQB: ACUT), a life sciences company dedicated to improving outcomes for patients with cancer, announced that its Chairman of the Board, Mr. Gabriele Cerrone, has notified the Company that he has recently purchased an additional 9,447 ACUT shares in the open market. This brings his total holding to 3,801,226 shares.
Gabriele Cerrone commented, “These open market share purchases of ACUT stock reflect my absolute confidence in what we are building at AccuStem. As the largest shareholder of AccuStem, my interests continue to be fully aligned with my fellow shareholders. I look forward to continuing to execute our plan to drive value for shareholders.”
About AccuStem
AccuStem is a life sciences company dedicated to optimizing outcomes for all patients with cancer across the globe. The company takes a holistic view of its role in oncology- to empower patients and their care team with critical answers and tools and drive innovation in healthcare.
Media Contact:
Jeff Fensterer
Phone: 415-640-6010
Email: jeff@accustem.com
Investor Contact:
Wendy Blosser
Email: investors@accustem.com
KARACHI, Pakistan, Dec. 22, 2025 /PRNewswire/ -- MindHYVE.ai, Inc., and Khoja (Pirhai) Shia Isna Asheri Jamaat…
Board-certified plastic surgeon and surgeon-scientist honored for clinical excellence, leadership, and commitment to patient education. …
New "Recovery Logistics" checklist helps patients coordinate work, childcare, travel, and follow-up support-before they choose…
Board-certified plastic surgeon shares a practical, question-based guide to help patients verify credentials, facility standards,…
ASPS trend reporting highlights facelift combined with eyelid surgery as a leading 2025 combination; national…
SAN DIEGO, CA / ACCESS Newswire / December 22, 2025 / CV Sciences, Inc. (OTCQB:CVSI)…